Search - Inserm - Institut national de la santé et de la recherche médicale Access content directly

Filter your results

19 Results
authFullName_s : Florence Cymbalista

Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact

Panagiotis Baliakas , Sabine Jeromin , Michalis Iskas , Anna Puiggros , Karla Plevova , et al.
Blood, 2019, 133 (11), pp.1205-1216. ⟨10.1182/blood-2018-09-873083⟩
Journal articles hal-03946254v1

Prevalence, distribution and predictive value of XPO1 mutation in a real‐life chronic lymphocytic leukaemia cohort

Giulia Tueur , Gregory Lazarian , Virginie Eclache , Carole Fleury , Rémi Letestu , et al.
British Journal of Haematology, 2020, 191 (3), pp.e90-e94. ⟨10.1111/bjh.17046⟩
Journal articles hal-03942496v1

CLL-240 Frequency of IKZF3 L162R Mutation in B-Cell Lymphoproliferative Disorders

Assia Taleb , Carole Fleury , Florence Cymbalista , Fanny Baran-Marszak , Gregory Lazarian
SOHO, Sep 2022, Houston (Texas), United States. 22, pp.S274, 2022, ⟨10.1016/s2152-2650(22)01338-6⟩
Conference poster inserm-03950175v1

A primitive plasma cell leukemia with immunoglobulin (Ig) E

Meriem Rachidi , Gregory Lazarian , Rémi Letestu , Daniel Lusina , Cedric Desbene , et al.
2019, pp.557-561. ⟨10.1684/abc.2019.1476⟩
Other publications hal-03942510v1
Image document

Impact of Low-Burden TP53 Mutations in the Management of CLL

Gregory Lazarian , Florence Cymbalista , Fanny Baran-Marszak
Frontiers in Oncology, 2022, 12, ⟨10.3389/fonc.2022.841630⟩
Journal articles hal-03942466v1

Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study

Anne Quinquenel , Luc-Matthieu Fornecker , Remi Letestu , Loic Ysebaert , Carole Fleury , et al.
Blood, 2019, 134 (7), pp.641-644. ⟨10.1182/blood.2019000854⟩
Journal articles hal-02301308v1

Characterisation of a new clinical presentation of chronic lymphocytic leukaemia: symptomatic bronchial involvement, a study from the FILO group

Morgane Nudel , Fanny Baran‐marszak , Jean‐baptiste Bossard , Romain Dubois , Héloïse Dapvril , et al.
British Journal of Haematology, 2019, 186 (5), pp.e126-e130. ⟨10.1111/bjh.15966⟩
Journal articles hal-02301300v1
Image document

Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma

Gregory Lazarian , Chloe Friedrich , Anne Quinquenel , Julie Tran , Souhail Ouriemmi , et al.
Oncogene, 2020, 39 (14), pp.2934-2947. ⟨10.1038/s41388-020-1183-x⟩
Journal articles inserm-02534412v1

TP53, XPO1 and ATM Mutations Exclusive Distribution in the Adverse Prognosis Chronic Lymphocytic Leukemia (CLL) Group

Giulia Tueur , Virginie Eclache , Grégory Lazarian , Carole Fleury , Rémi Letestu , et al.
SOHO, Sep 2018, Houston (Texas), United States. 18, pp.S218, 2018, ⟨10.1016/j.clml.2018.07.084⟩
Conference poster inserm-03950185v1
Image document

TP53 mutations at codon 234 are associated with chlorambucil treatment in chronic lymphocytic leukemia

Grégory Lazarian , Floriane Theves , Myriam Hormi , Rémi Letestu , Virginie Eclache , et al.
American Journal of Hematology, 2022, 97 (4), pp.E159-E162. ⟨10.1002/ajh.26479⟩
Journal articles hal-03557401v1

Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21

Rim Zaaboub , Lene Vimeux , Vincent Contremoulins , Florence Cymbalista , Vincent Lévy , et al.
Blood Advances, 2022, 6 (16), pp.4691-4704. ⟨10.1182/bloodadvances.2021006169⟩
Journal articles hal-03869266v1

IKZF3 Overexpression Phenocopies Gain-of-Function Mutation in Chronic Lymphocytic Leukemia

Shanye Yin , Gregory Lazarian , Elisa ten Hacken , Tomasz Sewastianik , Satyen Gohil , et al.
ASH, Dec 2020, San Diego, United States. pp.9-9, ⟨10.1182/blood-2020-137085⟩
Conference papers inserm-03950169v1

The Broad Spectrum of TP53 Variants in CLL: NGS Analysis of 573 Pathogenic TP53 Variants

Gregory Lazarian , Floriane Theves , Myriam Hormi , Virginie Eclache , Stéphanie Poulain , et al.
ASH, Dec 2019, Orlando (Florida), United States. 134 (Supplement_1), pp.3021-3021, 2019, ⟨10.1182/blood-2019-130907⟩
Conference poster inserm-03950178v1
Image document

Clinical, biological, and molecular genetic features of Richter syndrome and prognostic significance: a study of the French Innovative Leukemia Organization

Charline Moulin , Francis Guillemin , Thomas Remen , Florian Bouclet , Sébastien Hergalant , et al.
American Journal of Hematology, 2021, 96 (9), pp.E311-E314. ⟨10.1002/ajh.26239⟩
Journal articles hal-03238759v1
Image document

Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis

Julien Broséus , Sébastien Hergalant , Julia Vogt , Eugen Tausch , Markus Kreuz , et al.
Nature Communications, 2023, 14 (1), pp.309. ⟨10.1038/s41467-022-34642-6⟩
Journal articles hal-03950368v1

Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization ( FILO )

Grégory Lazarian , Michaël Munger , Anne Quinquenel , Marie‐sarah Dilhuydy , Lauren Veronese , et al.
American Journal of Hematology, 2021, 96 (9), pp.E353-E356. ⟨10.1002/ajh.26274⟩
Journal articles hal-03464731v1

A hotspot mutation in transcription factor IKZF3 drives B cell neoplasia via transcriptional dysregulation

Gregory Lazarian , Shanye Yin , Elisa ten Hacken , Tomasz Sewastianik , Mohamed Uduman , et al.
Journal articles hal-03942490v1

A fixed-duration, measurable residual disease–guided approach in CLL: follow-up data from the phase 2 ICLL-07 FILO trial

Anne-Sophie Michallet , Rémi Letestu , Magali Le Garff-Tavernier , Carmen Aanei , Michel Ticchioni , et al.
Blood, 2021, 137 (8), pp.1019-1023. ⟨10.1182/blood.2020008164⟩
Journal articles hal-03231146v1

Real-world outcomes following venetoclax therapy in patients with chronic lymphocytic leukemia or Richter syndrome: a FILO study of the French compassionate use cohort

Florian Bouclet , Anne Calleja , Marie-Sarah Dilhuydy , Lauren Véronèse , Bruno Pereira , et al.
Annals of Hematology, 2021, 100 (4), pp.987-993. ⟨10.1007/s00277-021-04419-w⟩
Journal articles hal-03441025v1